🇺🇸 FDA
Patent

US 11993584

Solid forms of an azolopyrimidine compound

granted A61KA61K31/506A61K45/06

Quick answer

US patent 11993584 (Solid forms of an azolopyrimidine compound) held by Arcus Biosciences, Inc. expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arcus Biosciences, Inc.
Grant date
Tue May 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/506, A61K45/06